| P50 | author | Youngkeun Ahn | Q87419336 |
| P2093 | author name string | Ju Han Kim | |
| | Myung Ho Jeong | |
| | Sang Rok Lee | |
| | Jeong Gwan Cho | |
| | Jong Chun Park | |
| | Jung Chaee Kang | |
| | Kye Hun Kim | |
| | Young Joon Hong | |
| | Hyung Wook Park | |
| | Weon Kim | |
| | Seo Na Hong | |
| P2860 | cites work | Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis | Q28187825 |
| | Intracoronary radiation therapy | Q34207347 |
| | Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty | Q34336722 |
| | Drug-eluting stents: cost versus clinical benefit | Q35160536 |
| | Drug-eluting stents: costs versus clinical benefit | Q35160541 |
| | Hippocrates revisited: the evidence for drug-eluting stents | Q35160546 |
| | The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 |
| | A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies | Q37638598 |
| | Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications | Q38648794 |
| | Local drug delivery for the prevention of restenosis. Fact, fancy, and future | Q40630968 |
| | Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease | Q41017012 |
| | 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. | Q41123265 |
| | Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model | Q43727885 |
| | Pathological analysis of local delivery of paclitaxel via a polymer-coated stent | Q43978575 |
| | Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent | Q44072451 |
| | Systemic drug therapy for restenosis: "déjà vu all over again". | Q44196687 |
| | Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). | Q44244528 |
| | Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization | Q44612131 |
| | Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model | Q45014996 |
| | Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial | Q47371323 |
| | Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung, and Blood Institute PTCA Registry. | Q50584299 |
| | The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (abciximab: ReoPro)-coated stent in acute myocardial infarction. | Q51253557 |
| | Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting. | Q51315113 |
| | Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries. | Q51600960 |
| | Pathology of Acute and Chronic Coronary Stenting in Humans | Q58492259 |
| | A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) | Q64948282 |
| | Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty | Q67278737 |
| | Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty | Q67299486 |
| | Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model | Q67733219 |
| | Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils | Q68499801 |
| | Preventive effects of the heparin-coated stent on restenosis in the porcine model | Q73091870 |
| | Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months | Q73321703 |
| | Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen | Q73356312 |
| | Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study | Q73368849 |
| | In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia | Q74027568 |
| | Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during n | Q74422055 |
| | Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome | Q74493440 |
| | Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty | Q77958677 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | inflammation | Q101991 |
| | coronary restenosis | Q18556246 |
| P304 | page(s) | 802-809 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Journal of Korean Medical Science | Q24039955 |
| P1476 | title | Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model | |
| P478 | volume | 22 | |